Drugs Made In America Acquisition (DMIIR) Profit After Tax (2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Profit After Tax came in at $4.3 million in Q4 2025, up 9482.14% on a QoQ basis from -$46158.0 in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Profit After Tax (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 1 years of Profit After Tax data on file, last reported at $4.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 3.89 Mn |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | 3.17 Mn |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | 2.22 Mn |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | 2.89 Mn |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 2.52 Mn |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | 2.55 Mn |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | 2.24 Mn |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | 2.67 Mn |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 2.17 Mn |
| 10 | Drugs Made In America Acquisition | - | - | - | 4.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | -46,158.00 |